Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
about
Drugs for the acute treatment of migraine in children and adolescentsThe optimal management of headaches in children and adolescentsEFNS guideline on the drug treatment of migraine - report of an EFNS task forceLong-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.Migraine headache in children.Overview of diagnosis and management of paediatric headache. Part II: therapeutic managementThe importance of placebo in headache research.Treatment of paediatric headache.Drug effects on salivary glands: dry mouth.Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review.Adverse drug reactions in the orofacial region.Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.The placebo responder rate in children and adolescents.Pediatric migraine: new diagnostic strategies and treatment options.The pharmacological treatment options for pediatric migraine: an evidence-based appraisal.Recommendations for the management of migraine in paediatric patients.Management of migraine in adolescents.Acute treatment of paediatric migraine: a meta-analysis of efficacy.Current therapies in childhood and adolescent migraine.A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.Almotriptan in the treatment of migraine.Triptans other than sumatriptan in child and adolescent migraine: literature review.Treating pediatric migraine: an expert opinion.The pharmacological treatment of migraine in children and adolescents: an overview.Pharmacological treatment of acute migraine in adolescents and children.The efficacy of triptans in childhood and adolescence migraine.Pediatric post-traumatic headaches and peripheral nerve blocks of the scalp: a case series and patient satisfaction survey.Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.Rizatriptan 5mg is not efficacious for migraine in adolescents.French general practitioners' management of children's migraine headaches.Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric MigraineursPediatric migraine
P2860
Q24185885-5AB1F4A9-6033-4089-83C5-EE2BCD51A017Q26770813-EC18C946-8393-4C35-9CDA-DA860A48F39EQ28219436-8B06FEF8-A99D-4E70-9F72-938CD9B9CD60Q33160296-46E38CA5-6388-4210-99E0-56CEAE289AE9Q33868355-B0AC3A72-814C-41AF-AC6F-65F528B68D40Q34770791-6074EAEE-0974-4BB4-8460-7D9C0839D4A7Q34813721-82FE5595-BBD5-45DA-8A00-8B2275B8964DQ34974806-0FB18140-D76A-4170-91DD-14F96A64EFAAQ35219131-8C5B3367-57C0-4E37-84F0-8C5FF34F9CD2Q35750750-1AF42CD0-0213-425C-AB23-54086A6A481FQ35850842-122FBE48-E950-4FB1-B717-CDB3F1F63E20Q36013751-1C0F42A9-0BE6-4543-B27E-EE6A6C3F9EC0Q36100812-B9C07C5A-9C7C-424A-A40E-1712F38C8ABAQ36419547-59882645-9A47-4C49-B979-8F8A6B33AF03Q36428744-BF2EFCF2-2EB6-4485-AF5F-6E8DAE816D7EQ36787278-D4B80C8B-68A1-453F-9C21-8A246D588495Q36853954-EA0BCA1E-1D73-465C-AA9D-112C02CFA256Q36940058-610696AE-B0A6-4C5F-9EFC-A35204C158A0Q37002459-AFF27E5F-CC7C-4FD3-BBB7-DE5278392EB9Q37123415-69644D0A-441D-4F34-BB14-5F2774106DFDQ37129812-7BDB9F36-78EC-44F9-B88E-89C5BF3B271AQ37849766-010B642F-4B83-4306-9B85-35E33F0EF30DQ38002459-2F46CE27-5DC8-4008-81C0-D922CF91AFC9Q38049630-ADB8E196-1C29-43F9-8955-ABF4BDF9099EQ38098096-0DFB1219-683C-4BCC-A571-DB70A23B207FQ38109574-42BED04B-B31C-446E-9344-B717EFD7DB24Q38201756-F5F7A97B-2D52-4973-9B6D-4472F310A0A8Q38461481-9FEBACF4-F485-479C-8E36-9623469B2E29Q39307655-A14046B0-979D-44E8-9D95-44249A937A3EQ39308490-A0C4F9DD-1DE4-4C80-861C-748EAD576D1BQ39375733-DFC3BF3E-4B1C-479A-BEC7-CD598292B29EQ42164910-B9D95C18-8CEC-4AAE-9C9A-470AE58215BDQ44187306-90F5942B-601C-43B1-A3F4-486560894AA7Q46957585-2AB219AF-865B-4D99-9B16-4CC6D49A73E4Q57197699-5533D59C-90EE-4706-B9FA-AA960B552490Q58647994-00EA6554-FFD5-48A3-A25D-36E3AD76A811
P2860
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@en
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@nl
type
label
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@en
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@nl
prefLabel
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@en
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@nl
P2093
P2860
P921
P1433
P1476
Rizatriptan 5 mg for the acute ...... ind, placebo-controlled study.
@en
P2093
Donald Lewis
Judith K Evans
Kaihong Jiang
Paul Winner
Rizatriptan Adolescent Study Group
Suzanne Ahrens
W Hester Visser
P2860
P356
10.1046/J.1526-4610.2002.02013.X
P577
2002-01-01T00:00:00Z